Search results
Bayer shares gain as another activist investor piles in
Reuters via Yahoo Finance· 1 year agoFRANKFURT (Reuters) -Bayer is facing demands from activist investor Bluebell Capital Partners to...
Bayer weighs break-up options as management job cuts loom
Reuters via Yahoo Finance· 6 months agoFRANKFURT (Reuters) -Bayer is considering breaking apart from its consumer health or crop science...
Bayer's (BAYRY) Q3 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 6 months agoBayer AG BAYRY reported third-quarter 2023 core earnings of 10 cents per American Depositary...
Bayer's agriculture unit, consumer health drive outlook hike
Reuters via Yahoo Finance· 2 years agoFRANKFURT (Reuters) -Agriculture and pharmaceuticals company Bayer on Thursday lifted its 2022...
Bayer reaches $6.9 million settlement with New York over Roundup safety claims
Reuters via Yahoo Finance· 11 months agoNEW YORK (Reuters) -Bayer AG agreed on Thursday to pay $6.9 million to settle claims by New York...
Bayer’s new CEO signals business shake-up, plans to slash management
BioPharma Dive via Yahoo Finance· 6 months agoCompany head Bill Anderson said Bayer may separate its consumer health or crop science business, and...
Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q1
Zacks via Yahoo Finance· 2 years agoBayer AG BAYRY reported first-quarter 2022 core earnings of 99 cents per American Depositary Receipt...
Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
Fortune via Yahoo Finance· 2 months agoI was no stranger to the tensions at Bayer when I joined as CEO last June. Multiple complex...
Bayer isn’t splitting up, for now
BioPharma Dive via Yahoo Finance· 2 months agoBayer is keeping its three core businesses under one roof, at least for now, in a decision likely to ruffle some of the company’s investors. Speaking to...
Bayer investor criticizes Bayer chair for lack of initiative - WirtschaftsWoche
Reuters via Yahoo Finance· 1 year agoFRANKFURT (Reuters) -The Bayer investor Union Investment criticized Bayer's chair for a lack of...